Bank of New York Mellon’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Sell |
165,044
-107,725
| -39% | -$118K | ﹤0.01% | 3991 |
|
|
2025
Q1 | $267K | Hold |
272,769
| – | – | ﹤0.01% | 3737 |
|
|
2024
Q4 | $426K | Hold |
272,769
| – | – | ﹤0.01% | 3589 |
|
|
2024
Q3 | $1M | Sell |
272,769
-38,861
| -12% | -$143K | ﹤0.01% | 3132 |
|
|
2024
Q2 | $1.03M | Buy |
311,630
+149,522
| +92% | +$495K | ﹤0.01% | 3178 |
|
|
2024
Q1 | $691K | Buy |
162,108
+145,974
| +905% | +$622K | ﹤0.01% | 3342 |
|
|
2023
Q4 | $29K | Buy |
16,134
+2
| +0% | +$4 | ﹤0.01% | 4196 |
|
|
2023
Q3 | $32.1K | Buy |
16,132
+1,649
| +11% | +$3.28K | ﹤0.01% | 4201 |
|
|
2023
Q2 | $37.1K | Buy |
14,483
+715
| +5% | +$1.83K | ﹤0.01% | 4208 |
|
|
2023
Q1 | $55.2K | Buy |
+13,768
| New | +$55.2K | ﹤0.01% | 4171 |
|
|
2022
Q2 | – | Sell |
-32,589
| Closed | -$132K | – | 4674 |
|
|
2022
Q1 | $132K | Buy |
32,589
+13,305
| +69% | +$53.9K | ﹤0.01% | 4343 |
|
|
2021
Q4 | $212K | Buy |
+19,284
| New | +$212K | ﹤0.01% | 4257 |
|